Sleep duration and breast cancer: A prospective cohort study

Cancer Research

Volumn 65, Issue 20, 2005, Pages 9595-9600

  Verkasalo, Pia K ^a   Lillberg, Kirsi ^b   Stevens, Richard G ^f   Hublin, Christer ^c   Partinen, Markku ^e   Koskenvuo, Markku ^d   Kaprio, Jaakko ^a,d  

^a NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^b UNIVERSITY OF TURKU   (Finland)

^c FINNISH INSTITUTE OF OCCUPATIONAL HEALTH   (Finland)

^d UNIVERSITY OF HELSINKI   (Finland)

^e Rinnekoti Foundation Finland   (Finland)

^f UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BREAST CANCER; CANCER INCIDENCE; CANCER REGISTRY; CANCER RISK; COHORT ANALYSIS; CONFIDENCE INTERVAL; FEMALE; FINLAND; HUMAN; MAJOR CLINICAL STUDY; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RESTRICTION MAPPING; RISK FACTOR; SLEEP DISORDER; SLEEP TIME;

ADULT; BREAST NEOPLASMS; COHORT STUDIES; FEMALE; HUMANS; MIDDLE AGED; PROSPECTIVE STUDIES; QUESTIONNAIRES; RISK FACTORS; SLEEP; SLEEP DISORDERS; TWIN STUDIES; TWINS;

EID: 27144467429     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-05-2138     Document Type: Article

References (48)

1. Parkin DM, Bray FI, Devesa SS. Cancer burden in the year 2000. The global picture. Eur J Cancer 2001;37 Suppl 8:S4-66.
2. Key TJ, Verkasalo PK, Banks E. Epidemiology of breast cancer. Lancet Oncol 2001;2:133-40.
3. Sateia MJ, Nowell PD. Insomnia. Lancet 2004;364:1959-73.
4. Ohayon MM, Partinen M. Insomnia and global sleep dissatisfaction in Finland. J Sleep Res 2002;11:339-46.
5. Ohayon MM. Prevalence and correlates of nonrestorative sleep complaints. Arch Intern Med 2005;165:35-41.
6. Ohayon MM. Epidemiology of insomnia: what we know and what we still need to learn. Sleep Med Rev 2002;6:97-111.
7. Manni R, Ratti MT, Marchioni E, et al. Poor sleep in adolescents: a study of 869 17-year-old Italian secondary school students. J Sleep Res 1997;6:44-9.
8. National Sleep Foundation. The 2004 NSF National Sleep in America Poll. Washington: National Sleep Foundation; 2004 [updated 2005 April 14]. Available from: http://www.sleepfoundation.org.
9. Bliwise DL. Historical change in the report of daytime fatigue. Sleep 1996;19:462-4.
10. Bjorkelund C, Bengtsson C, Lissner L, Rodstrom K. Women's sleep: longitudinal changes and secular trends in a 24-year perspective. Results of the population study of women in Gothenburg, Sweden. Sleep 2002;25: 894-6.
11. Bonnet MH, Arand DL. We are chronically sleep deprived. Sleep 1995;18:908-11.
12. National Sleep Foundation. The 2005 NSF National Sleep in America Poll. Washington: National Sleep Foundation; 2005 [updated 2005 April 14]. Available from: http://www.sleepfoundation.org.
13. Groeger JA, Zijlstra FR, Dijk DJ. Sleep quantity, sleep difficulties and their perceived consequences in a representative sample of some 2000 British adults. J Sleep Res 2004;13:359-71.
14. Harrison Y, Horne JA. Should we be taking more sleep? Sleep 1995;18:901-7.
15. Brzezinski A. Melatonin in humans. N Engl J Med 1997;336:186-95.
16. Macchi MM, Bruce JN. Human pineal physiology and functional significance of melatonin. Front Neuroendocrinol 2004;25:177-95.
17. Stevens RG, Rea MS. Light in the built environment: potential role of circadian disruption in endocrine disruption and breast cancer. Cancer Causes Control 2001;12:279-87.
18. Stevens RG. Electric power use and breast cancer: a hypothesis. Am J Epidemiol 1987;125:556-61.
19. Aeschbach D, Sher L, Postolache TT, et al. A longer biological night in long sleepers than in short sleepers. J Clin Endocrinol Metab 2003;88:26-30.
20. Wehr TA. In short photoperiods, human sleep is biphasic. Sleep Res 1992;1:103-7.
21. Wehr TA. Photoperiodism in humans and other primates: evidence and implications. J Biol Rhythms 2001;16:348-64.
22. Kaprio J, Koskenvuo M. Genetic and environmental factors in complex diseases: the older Finnish Twin Cohort. Twin Res 2002;5:358-65.
23. Lillberg K, Verkasalo PK, Kaprio J, et al. Stress of daily activities and risk of breast cancer: a prospective cohort study in Finland. Int J Cancer 2001;91: 888-93.
24. Sarna S, Kaprio J, Sistonen P, Koskenvuo M. Diagnosis of twin zygosity by mailed questionnaire. Hum Hered 1978;28:241-54.
25. Romanov K, Appelberg K, Honkasalo M-L, Koskenvuo M. Recent interpersonal conflict at work and psychiatric morbidity: a prospective study of 15,530 employees aged 24-64. J Psychosom Res 1996;40:169-76.
26. Finnish Cancer Registry. Cancer Statistics for Finland. Helsinki: National Research and Development Centre for Welfare and Health [updated 2005 April 15]. Available at: http://www.cancerregistry.fi.
27. Teppo L, Pukkala E, Lehtonen M. Data quality and quality control of a population-based cancer registry. Experience in Finland. Acta Oncol 1994;33:365-9.
28. World Health Organization. International Classification of Diseases, 7th revision. World Health Organization; 1955.
29. Hublin C, Kaprio J, Partinen M, Koskenvuo M. Insufficient sleep-a population-based study in adults. Sleep 2001;24:392-400.
30. Tynes T, Hannevik M, Andersen A, Vistnes AI, Haldorsen T. Incidence of breast cancer in Norwegian female radio and telegraph operators. Cancer Causes Control 1996;7:197-204.
31. Davis S, Mirick DK, Stevens RG. Night shift work, light at night, and risk of breast cancer. J Natl Cancer Inst 2001;93:1557-62.
32. Hansen J. Increased breast cancer risk among women who work predominantly at night. Epidemiology 2001;12:74-7.
33. Schernhammer ES, Laden F, Speizer FE, et al. Rotating night shifts and risk of breast cancer in women participating in the Nurses' Health Study. J Natl Cancer Inst 2001;93:1563-8.
34. Verkasalo PK, Pukkala E, Stevens RG, Ojamo M, Rudanko SL. Inverse association between breast cancer incidence and degree of visual impairment in Finland. Br J Cancer 1999;80:1459-60.
35. Feychting M, Osterlund B, Ahlbom A. Reduced cancer incidence among the blind. Epidemiology 1998;9:490-4.
36. Kliukiene J, Tynes T, Andersen A. Risk of breast cancer among Norwegian women with visual impairment. Br J Cancer 2001;84:397-9.
37. Hahn RA. Profound bilateral blindness and the incidence of breast cancer. Epidemiology 1991;2: 208-10.
38. Travis RC, Allen DS, Fentiman IS, Key TJ. Melatonin and breast cancer: a prospective study. J Natl Cancer Inst 2004;96:475-82.
39. Schernhammer ES, Hankinson SE. Urinary melatonin levels and breast cancer risk. J Natl Cancer Inst 2005;97:1084-7.
40. Schernhammer ES, Rosner B, Willett WC, et al. Epidemiology of urinary melatonin in women and its relation to other hormones and night work. Cancer Epidemiol Biomarkers Prev 2004;13: 936-43.
41. Hill SM, Spriggs LL, Simon MA, Muraoka H, Blask DE. The growth inhibitory action of melatonin on human breast cancer cells is linked to the estrogen response system. Cancer Lett 1992;64:249-56.
42. Blask DE, Dauchy RT, Sauer LA, Krause JA, Brainard GC. Growth and fatty acid metabolism of human breast cancer (MCF-7) xenografts in nude rats: impact of constant light-induced nocturnal melatonin suppression. Breast Cancer Res Treat 2003;79:313-20.
43. Maestroni GJ. Therapeutic potential of melatonin in immunodeficiency states, viral diseases, and cancer. Adv Exp Med Biol 1999;467:217-26.
44. Reiter RJ, Tan DX. Melatonin: an antioxidant in edible plants. Ann N Y Acad Sci 2002;957:341-4.
45. Fu L, Lee CC. The circadian clock: pacemaker and tumour suppressor. Nat Rev Cancer 2003;3:350-61.
46. Stevens RG. Circadian disruption and breast cancer: from melatonin to clock genes. Epidemiology 2005;16: 254-8.
47. Sephton S, Spiegel D. Circadian disruption in cancer: a neuroendocrine-immune pathway from stress to disease? Brain Behav Immun 2003;17:321-8.
48. Youngstedt SD, Kripke DF. Long sleep and mortality: rationale for sleep restriction. Sleep Med Rev 2004;8:159-74.